Scott Gottlieb – Where Are They Now

Who he was in the COVID era

Former FDA commissioner (left Apr 2019). He joined Pfizer's board in Jun 2019 and was a CNBC contributor throughout the pandemic. Documented (he discloses the board seat himself)
- May 20, 2020 (post): "A window into efforts to produce a covid vaccine at Pfizer, where I serve on the company board of directors…"
- May 5, 2020 (post): "Proud of the work the people of @Pfizer are doing… as a member of the company's board of directors."
Remdesivir promotion:
- Mar 27, 2020 (post): "We may also have by summer or fall an anti-viral drug that acts directly against the virus. Remdesivir by Gilead is one of many agents showing preliminary activity. Such a drug can be used as both treatment and potentially post exposure prophylaxis if side effect profile is good"
- Film 00:32:07 (CNBC): "Remdesivir blocks viral replication. You want to get it in early…" Documented
The HCQ–remdesivir interaction:
- Jun 15, 2020 (post): "New FDA warning advises that… the co-administration of hydroxychloroquine with remdesivir may interfere with the antiviral activity of remdesivir and reduce remdesivir's effectiveness."
- Film 00:46:07: HCQ "could potentially interfere with the activity of remdesivir." Documented
- Pfizer later signed to manufacture remdesivir for Gilead. Documented
Aug 27, 2021 (post): "…Many continue to hold hydroxychloroquine is effective, even after definitive studies debunked its use…" Documented

On Aug 27, 2021, Gottlieb emailed Twitter public-policy manager Todd O'Boyle to flag a post by Dr. Brett Giroir (former acting FDA commissioner and HHS assistant secretary) arguing that natural immunity was superior to vaccine immunity. According to Alex Berenson's Twitter Files release, Twitter labeled Giroir's post "misleading" and restricted engagement, even though an internal analyst found no rule violation. Documented (the emails were published by Berenson. "Censorship" is the reporter's characterization.) Sources: Berenson, Unreported Truths; Anadolu Agency
Third-party X coverage at the time: @AsherPress, Jan 9, 2023; @MooreFay, Jan 9, 2023. (third-party posts)

00:32:03–00:32:12 — "Remdesivir blocks viral replication. You want to get it in early…" (Gottlieb, CNBC)
00:46:07–00:46:17 — HCQ studies: "some have shown a harm… could potentially interfere with the activity of remdesivir." (Gottlieb, CNBC)
00:46:21–00:46:40 — Narration: "This accidental admission that hydroxychloroquine interferes with a patient's ability to get sick enough to need remdesivir…"; Illumina board seat (Narration (film satire))
00:57:25–00:57:35 — Narration: "This accidental admission that China has beaten the virus was brought to you by… Scott Gottlieb. Scott's a board member of the company Pfizer. Four months after this interview, Pfizer announced it was manufacturing Gilead's very expensive remdesivir." (Narration (film characterization))
Full timecodes are in the annotated transcript.

Pfizer director compensation, FY2025: $393,500 ($185,000 cash + $205,000 stock + $3,500 other). He chairs Pfizer's Regulatory and Compliance Committee. Documented (Pfizer 2026 proxy) Sources: Pfizer 2026 proxy (SEC); compbrief summary
UnitedHealth Group board since Nov 2025. 2025 director compensation was $42,050 (stock). Documented Source: UNH 2026 proxy
Also on the Illumina and Tempus AI boards (per his bio). The film ties Illumina to Gates and Bezos via Grail (00:47:15). Documented (board seats per his own bio)

None. No discipline or lawsuit was found. Documented (absence as of Nov 2, 2026 ET)

Pfizer, Illumina, Tempus AI and UnitedHealth Group boards. AEI Senior Fellow, NEA partner, CNBC contributor. Documented (per his X bio, Nov 2, 2026)

Last reviewed November 2026 (research pass Nov. 2–3, 2026). This profile is updated as new records surface. Corrections: Press@EpidemicOfFraud.com